healthy volunteers (the control group). Patients were recruited from the Department of Gastroenterology, Medical University of Lublin, Lublin, Poland. The group of alcohol addicts comprised patients from the Department of Therapy of Addiction to Alcohol at the Neuropsychiatric Hospital in Lublin.
Diagnosis of chronic pancreatitis was established based on routine criteria: history of recurrent episodes of acute pancreatitis and abnormalities detected by imaging studies (ultrasonography, abdominal computed tomography, endoscopic retrograde cholangiopancreatography) such as calcifications, parenchymal fibrosis, calcified deposits in the pancreatic ducts, or widened/irregular ducts. In 3 patients, alcoholic chronic pancreatitis was histologically confirmed. Alcoholic etiology was determined on the basis of medical history, i.e., consumption of more than 80 g of pure ethanol/day (men) and more than 40 g of pure ethanol/day (women) over at least 2 years. Of 67 patients with alcoholic chronic pancreatitis, 24 had diabetes. The group of patients with nonalcoholic chronic pancreatitis consisted of patients who had the disease but did not have a personal history of alcohol abuse or a family history of chronic pancreatitis. In 4 patients, autoimmune pancreatitis was diagnosed on the basis of elevated serum immunoglobulin G4 levels. In 2 patients, the biliary origin of chronic pancreatitis was observed. In the remaining 29 cases, toxic, metabolic, and obstruction factors of chronic pancreatitis were excluded so they were considered to have idiopathic chronic pancreatitis.
The group of alcoholics without digestive tract pathologies consisted of individuals who complied with the DSM-IV criteria for alcohol addiction but in whom diagnostic tests excluded digestive pathology.
18 In all of them, laboratory tests showed normal results and abdominal ultrasonography did not reveal any abnormalities. Clinically significant diseases of digestive, respiratory, and circulatory tracts were excluded. All patients showed normal renal function.
The control group included healthy volunteers who reported no or very occasional alcohol consumption below 10 g of pure ethanol/year, so the alcohol dose was assumed as 0 g/day. These data were collected by a face-to-face interview. Controls did not have any evidence of a chronic disease, no disease was diagnosed at physical examination, and they had normal results of laboratory tests and abdominal ultrasonography. They were recruited from among the students and personnel of the Medical University of Lublin.
All participants were Caucasians and were ethnically homogenous. The study was conducted in accordance with the ethical principles of the 1975 Helsinki Declaration, and the study protocol was approved by the Commission of Bioethics at the Medical University of Lublin. All participants signed informed consent to take part in the study. Patient groups are described in From 20% to 30% of the cases of chronic pancreatitis are considered idiopathic. In 10% of the cases, the disease is related to other rare conditions such as hypoparathyroidism, malnutrition, bile duct disorders or abnormal morphology of the organ (pancreas divisum), scarring of the pancreatic ducts, and autoimmune diseases. [9] [10] [11] There are no precise data concerning hereditary pancreatitis, but it appears that its incidence is substantially lower than that of the above conditions. 12 Only from 5% to 10% alcohol addicts develop chronic pancreatitis, and numerous patients who do not drink alcohol at all also suffer from the disease. Therefore, other factors must probably be involved in its pathogenesis which confer individual risk. 3, 10, 13 Recent studies have suggested the essential role of genetic factors. Studies assessing the role of the polymorphism of genes that code the enzymes involved in ethanol metabolism have provided different results. A number of investigators observed that various polymorphic forms correlated with susceptibility to alcoholic chronic pancreatitis. Nevertheless, the results still remain inconclusive. [14] [15] [16] Among many genetic factors likely to be associated with various etiological forms of chronic pancreatitis are: mutations of the cationic trypsinogen gene (PRSS1), the serine protease inhibitor Kazal type 1 gene (SPINK1), the chymotrypsin gene (CTRC), the cystic fibrosis transmembrane conductance regulator gene (CFTR), the calcium--sensing receptor gene (CASR), and genes coding such cytokines as interleukins, tumor necrosis factor α, transforming growth factor β1, and interferon γ, vascular endothelial growth factor, and intercellular adhesion molecule 1.
17 The pancreatic secretory trypsin inhibitor (PST1) is a 79 amino acid peptide encoded by the SPINK1 gene and it operates as an inhibitor of trypsin activity. Therefore, it acts as a barrier or first-line defense against accidental premature activation of trypsinogen in acinar pancreatic cells. 1,17 The N34S mutation in exon 3 of the SPINK1 gene was identified in patients with chronic pancreatitis. Many studies focused on the relation between chronic pancreatitis of various origin and the N34S mutation in different populations. However, this issue have been poorly investigated in the Polish population.
The purpose of the present study was to establish the differences in the frequency of the SPINK1 N34S mutation between patients with alcoholic chronic pancreatitis, nonalcoholic chronic pancreatitis, alcohol addicts (alcoholics) without any digestive organ damage, and controls in the Polish population. We investigated whether N34S mutations of the SPINK1 gene occur with different frequency among men and women and whether the mutations affect the age of disease onset.
PATIENTs ANd mEThOds Patients A group of 207 patients were included in the study: 67 patients with alcoholic chronic pancreatitis, 35 with nonalcoholic chronic pancreatitis, 43 alcoholics with no damage to digestive organs, and 62 2 Sequential mixture contained 4 µl of BigDye Terminator v 3.1 (Applied Biosystems, country), 2 µl of Sequencing Buffer (Applied Biosystems), 3.2 pmol of primer R, and 1 µl of template DNA; all were completed with water to the volume of 10 µl. Sequencing was conducted in the Biometra thermocycler under the following conditions: initial denaturation at 96 o C for 1 minute, then 25 cycles of denaturation at 96 o C for 10 seconds, annealing at 50 o C for 5 seconds, extension at 60 o C for 4 minutes. 3 Sequencing products were purified on spin microcolumns (A&A Biotechnology). 4 Capillary electrophoresis of the sequencing products was performed in ABI Pism 3100 with the capillary length of 36 cm (Applied Biosystems) and polimer POP-6 (Applied Biosystems). 5 Results were analyzed by Sequencing Analysis (Applied Biosystems) 19 modified by Michalak (unpublished data).
statistical analysis The characteristics of the study population were analyzed and the comparison of the age of disease onset was performed using the t test for independent samples. To compare the frequency of the SPINK1 N34S mutation between the study groups, the χ 2 test with Yates' correction was used. Statistical significance between the differences was assumed at the level of P less than 0.05. All calculations were performed using the STATISTICA PL software.
REsuLTs
In the study group of 207 subjects, the N34S mutation of the SPINK1 gene occurred with the frequency of 7.25%. All mutations were heterozygotic (FIGuREs 1 and 2). TAbLE 2 presents the frequency of the SPINK1 N34S mutation in the study groups. The mutation was most frequent in the group of patients with alcoholic chronic pancreatitis (16.39%) and was more frequent compared with the control group (P = 0.047). The differences between the other examined groups were statistically insignificant.
The N34S mutation of the SPINK1 gene was more frequent in the group of men than in the group of women (10.14% vs. 1.45%; χ 2 = 3.96; P = 0.043; odds ratio, 7.68; 95% confidence interval, 0.99-59.65).
The age of disease onset was similar in the groups of patients with and without the N34S mutation of the SPINK1 gene (TAbLE 3) . methods Genomic DNA was extracted from peripheral blood using the spin microcolumns (Blood Mini, A&A Biotechnology, Poland). Purity and quality of the extracted DNA was verified by electrophoresis in 2% agarose gel (Sigma, United States) stained with ethidium bromide and visualized under ultraviolet light transiluminator (Biometra, Germany). For the detection of the N34S mutation (located within exon 3 of the SPINK1 gene), the polymerase chain reaction (PCR)-restriction fragment length polymorphism technique was used. The reaction mixture (25 µl) contained: 2.5 µl of 2 mM dNTP mix (MBI Fermentas, Lithuania), 2.5 µl of 10-fold concentrated reaction buffer (MBI Fermentas), 2.5 µl of 25 mM After amplification, each sample (25 µl) was divided into 3 parts each with 8 µl. The first part was subjected to electrophoresis in 3% agarose gel stained with ethidium bromide, voltage -220V. Jules size marker (MBI Fermentas) was subjected with amplicifation products. If the product length of 325 bp was observed, the remaining 2 parts of this sample were digested with 1 µl PstI Fast Digest enzyme (MBI Fermentas) The findings concerning the N34S mutation of the SPINK1 gene and alcoholic chronic pancreatitis in the Polish population are in contrast with the study by Gąsiorowska et al. 20 who found no such correlations in the group of adult Polish patients. However, their study focused on idiopathic pancreatitis (P <0.05) and they investigated a smaller group of patients (34 with alcoholic pancreatitis and 14 with idiopathic pancreatitis), which may in part explain the discrepancy in the results. 20 We observed that all cases with the N34S mutation of the SPINK1 gene where heterozygous, which was in disagreement with the study by Gąsiorowska et al.
20 who observed 6 homozygous cases. On the other hand, our results are in line with their findings 20 on the high incidence of the SPINK1 N34S mutation of the gene among Polish patients with alcoholic chronic pancreatitis and among the controls (they reported 18% and 6.5%, respectively). Moreover, similarly to Gąsiorowska et al., 20 we showed no effect of the mutation on the mean age of disease onset.
dIsCussION Methods of molecular genetics have been used to investigate the pathogenesis of chronic pancreatitis. Recent studies have provided controversial results suggesting the involvement of the N34S mutation of the SPINK1 gene, which occurs with varied frequency in particular populations of patients and plays a variablerole in the etiology of different forms of chronic pancreatitis.
Our study is the first to have investigated the frequency of the SPINK1 N34S mutation in men and women. We observed that the mutation was more frequent in men than in women. Moreover, we revealed higher incidence of this mutation in Polish patients with alcoholic chronic pancreatitis (16.39%) and the control group (3.23%) compared with the results presented by other authors. This may suggest that the SPINK1 N34S mutation may affect the development of alcoholic chronic pancreatitis in Polish individuals. No such correlation was observed for nonalcoholic pancreatitis. of the SPINK1 gene may result from small study cohorts, which is a crucial limitation in genetic studies.
In conclusion, the N34S mutation of the SPINK1 gene appears to be significantly correlated with alcoholic chronic pancreatitis in Polish individuals. No such correlation was found in patients with chronic pancreatitis of other etiology and among alcoholics without digestive pathology. This mutation is more common in men than in women and does not affect the age of disease onset. According to the European reports, the SPINK1 N34S mutation occurs with the frequency of 1% to 4% in the general population in the European countries, while it is substantially more frequent in cases of alcohol-related chronic pancreatitis (2.2%-10%) and in patients with idiopathic pancreatitis (25%). 1, [21] [22] [23] [24] The presence of this mutation was estimated to be between 0.8% and 2.6% in healthy individuals and 1.0% in alcoholics without chronic pancreatitis. 21 In our study, the incidence of the SPINK1 N34S mutation in the examined subjects was higher than in the majority of the European reports.
Similarly to our findings, the incidence of the mutation in Dutch and Finish populations showed a marked correlation with alcoholic chronic pancreatitis. 1,23 However, data from the studies on the British population showed no significant effect of the SPINK1 N34S mutation on alcoholic chronic pancreatitis.
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American studies reported the N34S mutation of the SPINK1 gene in 6.3% of the patients with alcoholic chronic pancreatitis, in 1.6% of the controls (P >0.05), and in 10.3% of the patients with nonalcoholic chronic pancreatitis (P <0.005), which is not in line with our findings. As in our study, they did not find any differences in the course of the disease or the onset age between the groups of patients with alcoholic and nonalcoholic pancreatitis. 25 Based on a comprehensive literature research by Aoun et al. 26 (who investigated 24 case-control studies), a strong relationship between the N34S mutation of the SPINK1 gene and idiopathic and tropical pancreatitis and a slightly weaker correlation with alcoholic chronic pancreatitis can be postulated.
The studies conducted in the Far East reported different results in patients with alcoholic chronic pancreatitis. The N34S mutation of the SPINK1 gene was not observed among Japanese patients with alcoholic chronic pancreatitis; however, the mutation occurred significantly more frequently (21.1%) in patients with nonalcoholic pancreatitis than in controls (0.6%). The authors underlined a correlation between the mutation and idiopathic and familial chronic pancreatitis but the involvement of the mutation in alcoholic chronic pancreatitis was less evident. However, the role of the N34S mutation was confirmed in developing susceptibility to earlier age of disease onset.
27
In India, the N34S mutation of SPINK1 gene was noted in 26.8% of the patients with alcoholic chronic pancreatitis compared with 2.76% in the control group (P <0.001). It did not affect the course of pancreatitis and the age of disease onset. 28 Contrary to that, Korean studies found that the mutation did not affect the development of alcoholic chronic pancreatitis and occurred in 2.4% of the examined patients; surprisingly, the mutation was not observed in controls.
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The inconclusive results of numerous studies on the associations between the N34S mutation
